Unknown

Dataset Information

0

Patient-reported outcomes in systemic AL amyloidosis with functional assessment of cancer therapy-general (FACT-G) and patient-reported outcomes measurement information system-global health (PROMIS-GH) in a real-world population.


ABSTRACT: We performed an observational study on health-related quality of life (HRQoL) in patients with AL amyloidosis diagnosed between 2012 and 2017 at our institution. A total of 81 patients were included, with a median age of 64 years. The mean FACT-G (Functional Assessment of Cancer Therapy-General) total score at baseline (?2 months from diagnosis) was 74 (±15), compared to a normative score of 80 (±18) in the general U.S. population. Significant HRQoL deficit was noted only in the functional well-being (FWB) domain of FACT-G. Using PROMIS-GH (Patient-Reported Outcomes Measurement Information System-Global Health) at baseline (n?=?18), a greater deficit was noted in the global physical health (GPH) compared to global mental health (GMH) domain. FACT-FWB and PROMIS-GPH domain scores were able to significantly discriminate between revised Mayo stages. Development and validation of an amyloid-specific PRO instrument incorporating specific domains of interest is urgently needed to pursue patient-centered drug development.

SUBMITTER: Chakraborty R 

PROVIDER: S-EPMC6928422 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Patient-reported outcomes in systemic AL amyloidosis with functional assessment of cancer therapy-general (FACT-G) and patient-reported outcomes measurement information system-global health (PROMIS-GH) in a real-world population.

Chakraborty Rajshekhar R   Rybicki Lisa L   Tomer Jacqulyn J   Samaras Christy J CJ   Faiman Beth M BM   Valent Jason J   Majhail Navneet S NS  

Leukemia & lymphoma 20190705 14


We performed an observational study on health-related quality of life (HRQoL) in patients with AL amyloidosis diagnosed between 2012 and 2017 at our institution. A total of 81 patients were included, with a median age of 64 years. The mean FACT-G (Functional Assessment of Cancer Therapy-General) total score at baseline (≤2 months from diagnosis) was 74 (±15), compared to a normative score of 80 (±18) in the general U.S. population. Significant HRQoL deficit was noted only in the functional well-  ...[more]

Similar Datasets

| S-EPMC8477486 | biostudies-literature
| S-EPMC5734956 | biostudies-literature
| S-EPMC4285435 | biostudies-literature
| S-EPMC7293395 | biostudies-literature
| S-EPMC6032515 | biostudies-literature
| S-EPMC7275879 | biostudies-literature
| S-EPMC5625814 | biostudies-literature
| S-EPMC5479355 | biostudies-literature
| S-EPMC6207259 | biostudies-literature
| S-EPMC6824268 | biostudies-literature